Want to see GUTS full AI Analyst Report?
Fractyl Health, Inc. (GUTS) Ratios
Fractyl Health, Inc. Ratios
GUTS's free cash flow for Q2 2026 was $-15.90M. For the 2026 fiscal year, GUTS's free cash flow was increased by $0.00 and operating cash flow was $-15.90M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.78 | 3.63 | 3.19 | 7.06 | 4.07 |
| Quick Ratio | 4.78 | 3.63 | 3.18 | 7.06 | 4.07 |
| Cash Ratio | 4.45 | 3.41 | 3.00 | 6.74 | 4.04 |
| Solvency Ratio | -1.25 | -0.85 | -0.19 | -0.15 | -0.12 |
| Operating Cash Flow Ratio | -4.93 | -3.31 | -3.83 | -6.33 | -1.41 |
| Short-Term Operating Cash Flow Coverage | -17.70 | 0.00 | -15.68 | 0.00 | -2.13 |
| Net Current Asset Value | $ -24.37M | $ -7.89M | $ -365.63M | $ -261.65M | $ -215.49M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.51 | 0.58 | 4.90 | 5.03 | 2.97 |
| Debt-to-Equity Ratio | 6.52 | 2.20 | -1.15 | -1.22 | -1.45 |
| Debt-to-Capital Ratio | 0.87 | 0.69 | 7.68 | 5.63 | 3.20 |
| Long-Term Debt-to-Capital Ratio | 0.76 | 0.51 | 19.66 | 5.78 | 3.68 |
| Financial Leverage Ratio | 12.84 | 3.80 | -0.23 | -0.24 | -0.49 |
| Debt Service Coverage Ratio | -27.40 | 0.00 | -18.51 | 0.00 | -2.11 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -25.61 |
| Debt to Market Cap | 0.11 | 0.34 | 0.56 | 0.50 | 0.50 |
| Interest Debt Per Share | 4.82 | 1.44 | 7.85 | 6.44 | 6.42 |
| Net Debt to EBITDA | 0.14 | 0.07 | -6.73 | -5.26 | -5.76 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 46.24% | 35.83% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | -73864.52% | -42363.33% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | -73136.56% | -42125.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | -100570.97% | -42363.33% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | -73864.52% | -64242.50% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | -73864.52% | -64242.50% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -73864.52% | -64242.50% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 145.59% | 73.45% | 151.65% | 94.06% | 104.89% |
| Return on Assets (ROA) | -116.11% | -63.56% | -101.15% | -76.21% | -37.77% |
| Return on Equity (ROE) | -1490.32% | -241.68% | 23.72% | 18.41% | 18.50% |
| Return on Capital Employed (ROCE) | -93.93% | -105.92% | -78.18% | -92.06% | -46.81% |
| Return on Invested Capital (ROIC) | -89.50% | -100.29% | -75.03% | -89.96% | -38.64% |
| Return on Tangible Assets | -116.11% | -63.56% | -102.27% | -77.30% | -37.77% |
| Earnings Yield | -41.77% | -76.59% | -12.60% | -7.59% | -6.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 5.45 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.02 | 0.14 | 0.46 | 0.00 |
| Inventory Turnover | 0.00 | 0.68 | 1.05 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -23119.10 | -2208.41 | -791.37 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 66.92 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 532.90 | 346.04 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 23652.00 | 2621.36 | 791.37 | 0.00 |
| Operating Cycle | 0.00 | 532.90 | 412.96 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -7.07 | -1.50 | -0.90 | -0.97 | -0.70 |
| Free Cash Flow Per Share | -7.11 | -1.55 | -0.91 | -0.97 | -0.70 |
| Dividend Paid and CapEx Coverage Ratio | -162.17 | -37.12 | -119.28 | -825.77 | -656.12 |
| Capital Expenditure Coverage Ratio | -162.17 | -37.12 | -119.28 | -825.77 | -656.12 |
| Operating Cash Flow Coverage Ratio | -1.47 | -1.05 | -0.11 | -0.15 | -0.11 |
| Operating Cash Flow to Sales Ratio | 0.00 | -704.53 | -356.86 | 0.00 | 0.00 |
| Free Cash Flow Yield | -26.94% | -75.02% | -7.06% | -7.57% | -5.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.39 | -1.27 | -7.94 | -13.17 | -15.79 |
| Price-to-Sales (P/S) Ratio | 0.00 | 964.47 | 5097.94 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 35.68 | 3.16 | -1.88 | -2.42 | -2.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.71 | -1.33 | -14.17 | -13.21 | -18.25 |
| Price-to-Operating Cash Flow Ratio | -3.74 | -1.37 | -14.29 | -13.23 | -18.28 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | 0.07 | -0.17 | -0.67 | -0.52 |
| Enterprise Value Multiple | -2.27 | -1.25 | -18.83 | -17.76 | -22.64 |
| Enterprise Value | 317.52M | 84.73M | 951.95M | 869.29M | 820.62M |
| EV to EBITDA | -2.27 | -1.25 | -18.83 | -17.76 | -22.64 |
| EV to Sales | 0.00 | 911.09 | 7932.91 | 0.00 | 0.00 |
| EV to Free Cash Flow | -3.49 | -1.26 | -22.05 | -18.78 | -24.49 |
| EV to Operating Cash Flow | -3.52 | -1.29 | -22.23 | -18.80 | -24.52 |
| Tangible Book Value Per Share | 0.74 | 0.65 | -6.85 | -5.32 | -4.40 |
| Shareholders’ Equity Per Share | 0.74 | 0.65 | -6.83 | -5.30 | -4.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -11.03 | -1.58 | -1.62 | -0.98 | -0.81 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.52 | 0.94 | 1.05 |
| Research & Development to Revenue | 0.00 | 757.75 | 316.98 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 155.12 | 35.80 | 0.00 | 0.00 |
| Income Quality | 0.64 | 0.95 | 0.56 | 1.00 | 0.86 |
Currency in USD
